Source:http://linkedlifedata.com/resource/pubmed/id/18201864
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-2-25
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0885-3924
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
232-4
|
pubmed:meshHeading |
pubmed-meshheading:18201864-Adult,
pubmed-meshheading:18201864-Analgesics,
pubmed-meshheading:18201864-Humans,
pubmed-meshheading:18201864-Ischemia,
pubmed-meshheading:18201864-Ketamine,
pubmed-meshheading:18201864-Kidney Failure, Chronic,
pubmed-meshheading:18201864-Male,
pubmed-meshheading:18201864-Pain
|
pubmed:year |
2008
|
pubmed:articleTitle |
Use of ketamine for ischemic pain in end-stage renal failure.
|
pubmed:publicationType |
Letter,
Comment,
Case Reports
|